The medical polymer market would grow at a CAGR of 8.16% over the predicted time frame. The market is expected to increase in value from US$ 20.44 Bn in 2022 to US$ 38.3 Bn in 2030.
The on medical polymer Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2142
Report Scope of the Medical Polymer Market
| Report Coverage | Details |
| Market Size in 2022 |
USD 20.44 Billion |
| Market Size by 2030 |
USD 38.3 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.16% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, Processing Method and Geography |
| Companies Mentioned | BASF SE, NatureWorks LLC, Covestro AG, Celanese Corporation, Eastman Chemical Corporation, Evonik Industries AG, Dow Inc., Exxon Mobil Corporation, Arkema, Koninklijke DSM NV, Formosa Plastics Corporation, Foryou Medical, KRATON CORPORATION, SABIC, Trinseo S.A. |
A recent report provides crucial insights along with application based and forecast information in the Global Medical polymer Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Medical polymer market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Medical polymer market are included as given below:
Medical polymer Market Key Players
- BASF SE
- NatureWorks LLC
- Covestro AG
- Celanese Corporation
- Eastman Chemical Corporation
- Evonik Industries AG
- Dow Inc.
- Exxon Mobil Corporation
- Arkema
- Koninklijke DSM NV
- Formosa Plastics Corporation
- Foryou Medical
- KRATON CORPORATION
- SABIC
- Trinseo S.A.
Market Segments
By Product
- Fibers & Resins
- PVC
- PP
- PE
- PS
- Others (engineering thermoplastics such as nylon, PET, PLA, PHA, PA, PC, ABS)
- Medical Elastomers
- Styrene Block Copolymer
- Rubber latex (NR + Butyl Rubber+Silicone rubber)
- Others (TPU, TPO, TPV)
- Biodegradable Polymers
- Polyhydroxyalkanoate (PHA)
- Others
By Application
- Medical Device Packaging
- Medical Components
- Orthopedic Soft Goods
- Wound Care
- Cleanroom Supplies
- BioPharm Devices
- Mobility Aids
- Sterilization & Infection Prevention
- Tooth Implants
- Denture-based Materials
- Other Implants
- Others
By Processing Method
- Blow Fill Seal
- Extrusion Blow Molding
- Injection Stretch Blow Molding
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global medical polymer market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the medical polymer market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Polymers Market
5.1. COVID-19 Landscape: Medical Polymers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Polymers Market, By Product
8.1. Medical Polymers Market, by Product, 2022-2030
8.1.1 Fibers & Resins
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Medical Elastomers
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biodegradable Polymers
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Polyhydroxyalkanoate (PHA)
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Medical Polymers Market, By Application
9.1. Medical Polymers Market, by Application, 2022-2030
9.1.1. Medical Device Packaging
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medical Components
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Orthopedic Soft Goods
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Wound Care
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Cleanroom Supplies
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. BioPharm Devices
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Mobility Aids
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Sterilization & Infection Prevention
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Tooth Implants
9.1.9.1. Market Revenue and Forecast (2017-2030)
9.1.10. Denture-based Materials
9.1.10.1. Market Revenue and Forecast (2017-2030)
9.1.11. Other Implants
9.1.11.1. Market Revenue and Forecast (2017-2030)
9.1.12. Others
9.1.12.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Medical Polymers Market, By Processing Method
10.1. Medical Polymers Market, by Processing Method, 2022-2030
10.1.1. Blow Fill Seal
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Extrusion Blow Molding
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Injection Stretch Blow Molding
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Medical Polymers Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)
Chapter 12. Company Profiles
12.1. BASF SE
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. NatureWorks LLC
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Covestro AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Celanese Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Eastman Chemical Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Evonik Industries AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Dow Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Exxon Mobil Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Arkema
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Koninklijke DSM NV
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments